Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiko Miyazaki

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 2022
[Survey on the Provision of Drug Information by Pharmacists to Lactating Women]Seiko Miyazaki
Biological & Pharmaceutical Bulletin|July 2, 2023
Comparison of Addition of Indications for Antineoplastic Agents Approved in the United States and Japan from 2001 to 2020Toshiyuki Shizuya, Seiko Miyazaki
Biological & Pharmaceutical Bulletin|October 2, 2022
Comparison of New Drug Indications Approved in the United States, Europe, and Japan from 2001 to 2020Toshiyuki Shizuya, Seiko Miyazaki
Pharmacology Research & Perspectives|June 27, 2023
Analysis of safety specifications in risk management plan at the time of drug approval and addition of clinically significant adverse reactions in the package insert post-approval in JapanRieko Saito, Seiko Miyazaki
Chemical & Pharmaceutical Bulletin|November 2, 2020
Development of a Logic Model for Promoting Incorporation of the Concepts of Impurity-Related ICH Guidelines into Pharmacopoeias Based on Cause and Effect AnalysisMaki Matsuhama, Rieko Saito, Seiko Miyazaki
Congenital Anomalies|December 10, 2023
Investigation on the accumulation of background and pregnancy outcome information on cases consulted by the Japan Drug Information Institute in PregnancyNaho Yakuwa, Atsuko Murashima, Seiko Miyazaki
Expert Review of Medical Devices|June 26, 2018
Regulatory convergence of medical devices: a case study using ISO and IEC standardsKuniki Imagawa, Yoshiaki Mizukami, Seiko Miyazaki
Chemical & Pharmaceutical Bulletin|January 3, 2023
Comparative Study of General Notices in Pharmacopoeias in Japan, the United States, and EuropeKoko Tanaka, Rieko Saito, Maki Matsuhama, et al.
Cureus|October 20, 2025
Acute Myeloid Leukemia With RUNX1::RUNX1T1 Fusion Transformed From JAK2V617F-Mutated Polycythemia Vera: A Case ReportHidenori Tsukiji, Seiko Miyazaki, Tadafumi Iino, et al.
Therapeutic Advances in Drug Safety|November 17, 2025
Methotrexate use and risk of abnormal alanine aminotransferase elevation in children with rare inflammatory diseases: a self-controlled case series analysis using a pediatric electronic health record database in JapanMasayoshi Nakakuni, Azusa Hara, Kosuke Nakano, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 1, 2022
[Survey on the Provision of Drug Information by Pharmacists to Lactating Women]Seiko Miyazaki
Biological & Pharmaceutical Bulletin|July 2, 2023
Comparison of Addition of Indications for Antineoplastic Agents Approved in the United States and Japan from 2001 to 2020Toshiyuki Shizuya, Seiko Miyazaki
Biological & Pharmaceutical Bulletin|October 2, 2022
Comparison of New Drug Indications Approved in the United States, Europe, and Japan from 2001 to 2020Toshiyuki Shizuya, Seiko Miyazaki
Pharmacology Research & Perspectives|June 27, 2023
Analysis of safety specifications in risk management plan at the time of drug approval and addition of clinically significant adverse reactions in the package insert post-approval in JapanRieko Saito, Seiko Miyazaki
Chemical & Pharmaceutical Bulletin|November 2, 2020
Development of a Logic Model for Promoting Incorporation of the Concepts of Impurity-Related ICH Guidelines into Pharmacopoeias Based on Cause and Effect AnalysisMaki Matsuhama, Rieko Saito, Seiko Miyazaki
Congenital Anomalies|December 10, 2023
Investigation on the accumulation of background and pregnancy outcome information on cases consulted by the Japan Drug Information Institute in PregnancyNaho Yakuwa, Atsuko Murashima, Seiko Miyazaki
Expert Review of Medical Devices|June 26, 2018
Regulatory convergence of medical devices: a case study using ISO and IEC standardsKuniki Imagawa, Yoshiaki Mizukami, Seiko Miyazaki
Chemical & Pharmaceutical Bulletin|January 3, 2023
Comparative Study of General Notices in Pharmacopoeias in Japan, the United States, and EuropeKoko Tanaka, Rieko Saito, Maki Matsuhama, et al.
Cureus|October 20, 2025
Acute Myeloid Leukemia With RUNX1::RUNX1T1 Fusion Transformed From JAK2V617F-Mutated Polycythemia Vera: A Case ReportHidenori Tsukiji, Seiko Miyazaki, Tadafumi Iino, et al.
Therapeutic Advances in Drug Safety|November 17, 2025
Methotrexate use and risk of abnormal alanine aminotransferase elevation in children with rare inflammatory diseases: a self-controlled case series analysis using a pediatric electronic health record database in JapanMasayoshi Nakakuni, Azusa Hara, Kosuke Nakano, et al.
Pageof 2